Summary
Today, a wealth of information and data on patients exists, but is scattered across different platforms and systems. This makes it very hard to use this data effectively to improve patient care and rapidly implement effective (digital) solutions for healthcare.
The aim of IMPROVE is to develop an evidence-based, real-time framework capable of integrating information from patient reported outcome and experience measures (PROMs and PREMs) and patient preference information (PPI), as well as patient-generated health data (PGHD) from m-health and e-health technologies such as wearable devices and mobile apps. By drawing on this and other information such as real-world data, the IMPROVE framework will deliver new insights into the real-life behaviour of, and challenges faced by, patients of all ages living with complex health problems.
The IMPROVE framework will be integrated into an online platform designed to facilitate the smart use of patient inputs and evidence in the development of integrated healthcare solutions.
The platform will be tested via 10 use cases covering 5 disease areas (ophthalmology, oncology, cardiovascular disease, chronic inflammation, and neurology) in at least 6 different European countries and their national/regional healthcare systems.
Ultimately, by placing the patient at the centre of the system, the IMPROVE platform should advance the use of information on patient preferences and experiences in treatment selection decisions and medical device design. The project also hopes its framework will facilitate the faster market entry of patient-centric, cost-effective integrated care solutions to improve healthcare across the EU.
Achievements & News
July 2024
By placing patients at the centre of the system, IMPROVE should advance the use of patient-generated data in treatment decisions...
Participants
Show participants on mapUniversities, research organisations, public bodies, non-profit groups
- Agenzia Regionale Per La Salute Ed Il Sociale, Bari, Italy
- Ethniko Kentro Erevnas Kai Technologikis Anaptyxis, Thermi Thessaloniki, Greece
- Fachhochschule St. Polten GMBH, St Polten, Austria
- Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca, Barcelona, Spain
- Fundacio Institut D'Investigacio Biomedica De Bellvitge, Hospitalet De Llobregat, Spain
- Heinrich-Heine-Universitaet Duesseldorf, Düsseldorf, Germany
- Institut Za Ekonomska Raziskovanja, Ljubljana, Slovenia
- Laegemiddelstyrelsen, Kobenhavn S, Denmark
- Ortopedska Bolnisnica Valdoltra, Ankaran, Slovenia
- Splosna Bolnisnica Celje, Celje, Slovenia
- Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
- Tilburg University- Universiteit Van Tilburg, Tilburg, Netherlands
- Udg Alliance, Lausanne, Switzerland
- Universidad Politecnica De Madrid, Madrid, Spain
- Universiteit Utrecht, Utrecht, Netherlands
- Univerzitetni Klinicni Center Ljubljana, Ljubljana, Slovenia
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
- Institutet For Fremtidsforskning Forening, Kobenhavn, Denmark
- Iserundschmidt GMBH, Bonn, Germany
- Multimed Engineers SRL, Parma, Italy
- Predictby Research And Consulting S.L., Barcelona, Spain
Patient organisations
- Fondazione Italiana Sclerosi Multipla - Fism Ets, Genoa, Italy
Private companies
- Better Programska Oprema Doo, Ljubljana, Slovenia
IHI industry partners
- Dedalus Italia S.P.A., Firenze, Italy
- F. Hoffmann-La Roche AG, Basel, Switzerland
- Medtronic Iberica SA, Madrid, Spain
- Philips GMBH, Hamburg, Germany
- Philips Medical Systems Nederland BV, Best, Netherlands
Participants | |
---|---|
Name | EU funding in € |
Agenzia Regionale Per La Salute Ed Il Sociale | 71 375 |
Better Programska Oprema Doo | 370 938 |
Dedalus Italia S.P.A. | 1 327 515 |
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | 54 188 |
Fachhochschule St. Polten GMBH | 262 250 |
Fondazione Italiana Sclerosi Multipla - Fism Ets | 180 750 |
Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca | 222 819 |
Fundacio Institut D'Investigacio Biomedica De Bellvitge | 228 916 |
Heinrich-Heine-Universitaet Duesseldorf | 103 875 |
Institut Za Ekonomska Raziskovanja | 178 563 |
Institutet For Fremtidsforskning Forening | 190 750 |
Iserundschmidt GMBH | 227 625 |
Laegemiddelstyrelsen | 94 500 |
Medtronic Iberica SA | 612 440 |
Multimed Engineers SRL | 76 500 |
Ortopedska Bolnisnica Valdoltra | 63 563 |
Philips GMBH | 978 108 |
Philips Medical Systems Nederland BV | 3 021 288 |
Predictby Research And Consulting S.L. | 343 250 |
Splosna Bolnisnica Celje | 66 400 |
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | 662 000 |
Tilburg University- Universiteit Van Tilburg | 163 250 |
Universidad Politecnica De Madrid | 430 750 |
Universiteit Utrecht | 315 750 |
Univerzitetni Klinicni Center Ljubljana | 66 400 |
Total Cost | 10 313 763 |